Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about UCBJY

Recent news which mentions UCBJY

Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
Tickers BIIB NEWS UCBJF UCBJY
Tags UCBJY General Stories That Matter
From Benzinga
FDA Approves UCB's Psoriasis Drug For Expanded Use In Painful Inflammatory Skin Disease
Tickers NEWS UCBJF UCBJY
Tags Briefs News Health Care
From Benzinga
Biogen/UCB Partnered Autoimmune Disease Candidate Hits Primary Goal In Late-Stage Study, Sets Stage Another Pivotal Trial
Tickers BIIB NEWS UCBJF UCBJY
Tags UCBJY General Biotech
From Benzinga
Longboard Pharmaceuticals Boasts High-Value Epilepsy Assets, Analyst Initiates Coverage
Tickers LBPH NEWS UCBJF UCBJY
Tags Expert Ideas Briefs Stories That Matter
From Benzinga
Johnson & Johnson Seeks FDA Approval For Muscle Weakness Drug And Gears Up Showdown With Argenx and UCB
Tickers ARGX JNJ NEWS UCBJF
Tags ARGX UCBJY FDA
From Benzinga
Belgium-Based Pharma Firm UCB To Offload China Neurology, Allergy Business For $680M To Asset Management Companies
Tickers NEWS UCBJF UCBJY
Tags UCBJY General Biotech
From Benzinga
There's Optimism Around Longboard Pharmaceuticals' Anti-Seizure Candidate: Analyst Boosts Price Target
Tickers LBPH NEWS UCBJF UCBJY
Tags Health Care News UCBJF
From Benzinga
Dianthus' Monoclonal Antibody On Promising Pathway To Gaining The Upper Hand - Analyst
Tickers AZN DNTH SNY UCBJF
Tags Trading Ideas DNTH Health Care
From Benzinga
Skin Disease Focused MoonLake Immunotherapeutics Poised To Outshine Rivals, Analyst Asserts
Tickers MLTX SLRN UCBJF UCBJY
Tags MLTX Briefs Expert Ideas
From Benzinga
FDA Approves Rystiggo: The Only Treatment for Two Most Common Subtypes of Generalized Myasthenia Gravis in Adults
Tickers ARGX UCBJF UCBJY
Tags Biotech Benzinga Health Care
From Benzinga
Cantor On MoonLake Immunotherapeutics - Initiates On Inexpensive Valuation, Strong Catalyst Path
Tickers MLTX NVS UCBJF UCBJY
Tags Analyst Ratings Initiation UCBJF
From Benzinga
The Week Ahead In Biotech (May 30-June 4): FDA Decision For Eton's Partnered Epilepsy Drug, ASCO Conference Gets Underway And More
Tickers ABBV ALPN AUPH BLCO
Tags VRTX Benzinga Biotech
From Benzinga
‘The capitulation model for biotech is a Category 5 storm, the same as energy in 2020’ — why contrarians say the sector is a buy
Tickers BMY FATE IBB JNJ
Tags JNJ LIAN BE:UCB
From MarketWatch
UCB's Rare Childhood Epilepsy Drug Scores FDA Approval
Tickers UCBJF UCBJY
Tags Benzinga Health Care Biotech
From Benzinga
Biogen-Xbrane Enter License Agreement For Cimzia Referenced Biosimilar, Xcimzane
Tickers BIIB UCBJF UCBJY
Tags Market News UCBJY UCBJF
From Benzinga
The Week Ahead In Biotech (Jan 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, Samsara Vision IPO And More
Tickers ABT CUE DCPH ETON
Tags General IPOs FDA
From Benzinga
UCB's Bispecific Marks Phase 3 Win For Second Psoriatic Arthritis Study
Tickers UCBJF UCBJY
Tags Market News UCBJY UCBJF
From Benzinga
ZGNX Stock: The $1.9B UCB Deal That Has Zogenix Shares Zooming Higher Today
Tickers SOFI SONY UCBJY ZGNX
Tags UCBJY NASDAQ:ZGNX,OTCMKTS:UCBJY,NYSE:SONY,NASDAQ:SOFI SONY
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For September 2, 2021
Tickers ALKS ASMB BLDE CATB
Tags BZI/Ratings RGLS BLDE
From Benzinga
UCB Gets EU Approval For Bimekizumab In Psoriasis
Tickers NVS UCBJF UCBJY
Tags UCBJF Market News NVS
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 23, 2021
Tickers ACVA CADL CHK CLR
Tags RLYB SNPO UCBJY
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 23, 2021
Tickers ADVM AGESY AGFY AHH
Tags TTD VNE AGFY
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 9, 2021
Tickers ALGN ARGO ASLN BMBL
Tags BSBK DFS STKL
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.